SEC Form 4 · accession 0001144204-18-001701
CALADRIUS BIOSCIENCES, INC. · CLBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven S Myers
Director
Period of report
Jan 8, 2018
Accepted (ET)
Jan 10, 2018 · 4:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000320017
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Jan 8, 2018 | A | 8,747 | A | Jan 8, 2019 | Jan 8, 2028 | Common Stock | 8,747 | 8,747 | D |
Explanation of responses
- F1Each restricted stock unit represents the right to receive one share of the Issuer's common stock.
- F2The restricted stock units vest in full on the date that is one year from the date of grant.